用于血液系统恶性肿瘤免疫治疗的双特异性和三特异性免疫细胞衔接器
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.
62.9分
★★★☆☆
站内排序·非疗效
ALL SOURCES
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.
Trends in Nephrology: From nihilism to targeted treatment of antibody-mediated rejection.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。